Search results for "Streptozotocin"

showing 10 items of 46 documents

New 1,4-Dihydropyridines Down-regulate Nitric Oxide in Animals with Streptozotocin-induced Diabetes Mellitus and Protect Deoxyribonucleic Acid agains…

2015

Diabetes mellitus (DM) and its complications cause numerous health and social problems throughout the world. Pathogenic actions of nitric oxide (NO) are responsible to a large extent for development of complications of DM. Search for compounds regulating NO production in patients with DM is thus important for the development of pharmacological drugs. Dihydropyridines (1,4-DHPs) are prospective compounds from this point of view. The goals of this study were to study the in vivo effects of new DHPs on NO and reactive nitrogen and oxygen species production in a streptozotocin (STZ)-induced model of DM in rats and to study their ability to protect DNA against nocive action of peroxynitrite. STZ…

0301 basic medicineBlood GlucoseMaleDihydropyridinesNitric Oxide Synthase Type IIIXanthine DehydrogenaseDown-RegulationNitric Oxide Synthase Type IIDHPS030204 cardiovascular system & hematologyPharmacologyToxicologyEndothelial NOSKidneyNitric OxideProtective AgentsNitric oxideDiabetes Mellitus Experimental03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePeroxynitrous AcidmedicineAnimalsRats WistarReactive nitrogen speciesPharmacologybiologyGeneral MedicineDNAStreptozotocinReactive Nitrogen SpeciesRatsNitric oxide synthasePeroxynitrous acid030104 developmental biologyBiochemistrychemistryLiverbiology.proteinReactive Oxygen SpeciesPeroxynitritemedicine.drugBasicclinical pharmacologytoxicology
researchProduct

Effects of an Antimutagenic 1,4-Dihydropyridine AV-153 on Expression of Nitric Oxide Synthases and DNA Repair-related Enzymes and Genes in Kidneys of…

2016

Development of complications of diabetes mellitus (DM), including diabetic nephropathy, is a complex multi-stage process, dependent on many factors including the modification of nitric oxide (NO) production and an impaired DNA repair. The goal of this work was to study in vivo effects of 1,4-dihydropyridine AV-153, known as antimutagen and DNA binder, on the expression of several genes and proteins involved in NO metabolism and DNA repair in the kidneys of rats with a streptozotocin (STZ)-induced model of DM. Transcription intensity was monitored by means of real-time RT-PCR and the expression of proteins by immunohistochemistry. Development of DM significantly induced PARP1 protein express…

0301 basic medicineMalemedicine.medical_specialtyDihydropyridinesDNA RepairNitric Oxide Synthase Type IIIDNA repairPoly (ADP-Ribose) Polymerase-1Gene ExpressionNitric Oxide Synthase Type II030204 cardiovascular system & hematologyToxicologyKidneyNiacinStreptozocinNitric oxideDiabetes Mellitus ExperimentalDiabetic nephropathyHistones03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEnosInternal medicineGene expressionmedicineAnimalsRNA MessengerRats WistarGenePharmacologybiologyReverse Transcriptase Polymerase Chain ReactionKidney metabolismAntimutagenic AgentsGeneral Medicinemedicine.diseaseStreptozotocinbiology.organism_classificationPhosphoproteinsMolecular biologyRats030104 developmental biologyEndocrinologychemistrymedicine.drugBasicclinical pharmacologytoxicology
researchProduct

Liraglutide Ameliorates Erectile Dysfunction via Regulating Oxidative Stress, the RhoA/ROCK Pathway and Autophagy in Diabetes Mellitus

2020

Background Erectile dysfunction (ED) occurs more frequently and causes a worse response to the first-line therapies in diabetics compared with nondiabetic men. Corpus cavernosum vascular dysfunction plays a pivotal role in the occurrence of diabetes mellitus ED (DMED). The aim of this study was to investigate the protective effects of glucagon-like peptide-1 (GLP-1) analog liraglutide on ED and explore the underlying mechanisms in vivo and in vitro. Methods Type 1 diabetes was induced in rats by streptozotocin, and the apomorphine test was for screening the DMED model in diabetic rats. Then they were randomly treated with subcutaneous injections of liraglutide (0.3 mg/kg/12 h) for 4 weeks. …

0301 basic medicineautophagyRHOAerectile dysfunctionPharmacologymedicine.disease_cause03 medical and health sciences0302 clinical medicineDiabetes mellitusmedicineoxidative stressPharmacology (medical)PharmacologyliraglutideType 1 diabetesbiologybusiness.industryLiraglutidelcsh:RM1-950Autophagymedicine.diseaseStreptozotocinlcsh:Therapeutics. Pharmacology030104 developmental biologyErectile dysfunction030220 oncology & carcinogenesisdiabetes mellitusbiology.proteinbusinessOxidative stressmedicine.drugFrontiers in Pharmacology
researchProduct

1,4-Dihydropyridine derivatives without Ca2+-antagonist activity up-regulatePsma6mRNA expression in kidneys of intact and diabetic rats

2015

Impaired degradation of proteins by the ubiquitin-proteasome system (UPS) is observed in numerous pathologies including diabetes mellitus (DM) and its complications. Dysregulation of proteasomal degradation might be because of altered expression of genes and proteins involved in the UPS. The search for novel compounds able to normalize expression of the UPS appears to be a topical problem. A novel group of 1,4-dihydropyridine (1,4-DHP) derivatives lacking Ca2+-antagonists activities, but capable to produce antidiabetic, antioxidant and DNA repair enhancing effects, were tested for ability to modify Psma6 mRNA expression levels in rat kidneys and blood in healthy animals and in rats with str…

0301 basic medicinemedicine.medical_specialtyKidneyAntioxidantmedicine.medical_treatmentClinical BiochemistryCell BiologyGeneral MedicineBiologyStreptozotocinmedicine.diseaseBiochemistry03 medical and health sciences030104 developmental biologyReal-time polymerase chain reactionmedicine.anatomical_structureEndocrinologyDownregulation and upregulationInternal medicineDiabetes mellitusGene expressionmedicineGenemedicine.drugCell Biochemistry and Function
researchProduct

Urinary Bladder Weight and Function in a Rat Model of Mild Hyperglycemia and Its Treatment With Dapagliflozin

2019

Hypertrophy and dysfunction of the urinary bladder are consistently observed in animal models of type 1 and less consistently in those of type 2 diabetes. We have tested the effects of mild hyperglycemia (n = 10 per group) in a randomized, blinded study and, in a blinded pilot study, of type 2 diabetes (n = 6 per group) and its treatment with dapagliflozin (1 mg/kg per day) on weight, contraction, and relaxation of the rat bladder. Based on a combination of high-fat diet and a low dose of streptozotocin, animals in the main study reached a mean peak blood glucose level of about 300 mg/dl, which declined to 205 mg/dl at study end. This was associated with a small, if any, increase in bladder…

0301 basic medicinemedicine.medical_specialtyType 2 diabetesMuscle hypertrophyContractility03 medical and health scienceschemistry.chemical_compound0302 clinical medicinerelaxationDiabetes mellitusInternal medicineMedicinePharmacology (medical)DapagliflozinFenoterolOriginal ResearchPharmacologyUrinary bladderdiabetesbusiness.industrylcsh:RM1-950contractionmedicine.diseaseStreptozotocin030104 developmental biologymedicine.anatomical_structureEndocrinologylcsh:Therapeutics. Pharmacologychemistry030220 oncology & carcinogenesishyperglycemiabusinesshypertrophyurinary bladdermedicine.drugFrontiers in Pharmacology
researchProduct

PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells

2014

Background and Purpose PPARβ enhances insulin sensitivity in adipocytes and skeletal muscle cells, but its effects on insulin signalling in endothelial cells are not known. We analysed the effects of the PPARβ/δ (PPARβ) agonists, GW0742 and L165041, on impaired insulin signalling induced by high glucose in HUVECs and aortic and mesenteric arteries from diabetic rats. Experimental Approach Insulin-stimulated NO production, Akt-Ser 473 and eNOS-Ser 1177 phosphorylation, and reactive oxygen species (ROS) production were studied in HUVECs incubated in low- or high-glucose medium. Insulin-stimulated relaxations and protein phosphorylation in vessels from streptozotocin (STZ)-induced diabetic rat…

2. Zero hungerPharmacologymedicine.medical_specialtyPyruvate dehydrogenase kinaseInsulinmedicine.medical_treatmentPDK4Oxidative phosphorylationBiologyStreptozotocinmedicine.diseaseInsulin resistanceEndocrinologyInternal medicinemedicinePhosphorylationProtein phosphorylationmedicine.drugBritish Journal of Pharmacology
researchProduct

Effect of an aqueous extract of Ajuga iva on glycaemia, reverse cholesterol transport and atherogenic ratios in rats with streptozotocin-induced diab…

2008

Aqueous extractNutrition and DieteticsbiologyChemistryReverse cholesterol transportMedicine (miscellaneous)Pharmacologymedicine.diseaseStreptozotocinbiology.organism_classificationAjugaDiabetes mellitusmedicinemedicine.drugProceedings of the Nutrition Society
researchProduct

High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition.

2011

OBJECTIVE Because of confounding factors, the effects of dietary n-3 polyunsaturated fatty acids (PUFA) on type 1 diabetes remain to be clarified. We therefore evaluated whether fat-1 transgenic mice, a well-controlled experimental model endogenously synthesizing n-3 PUFA, were protected against streptozotocin (STZ)-induced diabetes. We then aimed to elucidate the in vivo response at the pancreatic level. RESEARCH DESIGN AND METHODS β-Cell destruction was produced by multiple low-doses STZ (MLD-STZ). Blood glucose level, plasma insulin level, and plasma lipid analysis were then performed. Pancreatic mRNA expression of cytokines, the monocyte chemoattractant protein, and GLUT2 were evaluate…

Blood GlucoseFatty Acid DesaturasesMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBlotting WesternMice TransgenicBiologyProinflammatory cytokineDiabetes Mellitus Experimentalchemistry.chemical_compoundMiceInternal medicineFatty Acids Omega-3Internal MedicinemedicineAnimalsInsulinCaenorhabditis elegans ProteinsUnsaturated fatty acidLipoxinReverse Transcriptase Polymerase Chain ReactionInsulinTranscription Factor RelAStreptozotocinImmunohistochemistryLipidsNitric oxide synthasemedicine.anatomical_structureEndocrinologyMetabolismchemistryHyperglycemiabiology.proteinGLUT2FemalePancreasmedicine.drugSignal TransductionDiabetes
researchProduct

Adrenic acid Δ4 desaturation and fatty acid composition in the liver of marine-oil fed streptozotocin diabetic rats

1998

The aim of the present study was to assess the effect of streptozotocin diabetes and insulin treatment on adrenic acid delta4 desaturation and fatty acid composition of liver microsomes in Wistar rats fed a fat free semi-synthetic basal diet supplemented with 10% EPA-rich marine oil. Results showed that, in liver microsomes of hyperglycemic rats, the 22:6n-3/22:5n-3 ratio in total lipids was elevated and desaturation of adrenic acid to n-6 docosapentaenoic acid was enhanced. Insulin treatment with 2.0 I.U./100 g body weight-1 twice a day for 3 days resulted in hypoglycemia and suppressed both the increased delta4 n-6 desaturation and 22:6n-3/22:5n-3 ratio. It is concluded that the delta4 de…

Blood GlucoseMaleErucic Acidsmedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryBiologyHypoglycemiaStreptozocinDiabetes Mellitus Experimentalchemistry.chemical_compoundFish OilsDiabetes mellitusInternal medicinemedicineAnimalsInsulinRats WistarChromatography High Pressure LiquidPancreatic hormoneInsulinFatty AcidsCell Biologymedicine.diseaseStreptozotocinLipidsEicosapentaenoic acidRatsEndocrinologyLiverBasal (medicine)chemistryFatty Acids UnsaturatedMicrosomes LiverDocosapentaenoic acidmedicine.drugProstaglandins, Leukotrienes and Essential Fatty Acids
researchProduct

Hypoglycaemic effect of Spergularia purpurea in normal and streptozotocin-induced diabetic rats

2000

Single and repeated oral administration of the water extracts of Spergularia purpurea (SP) at a dose of 10 mg/kg were tested on hypoglycaemic activity in normal and streptozotocin-induced diabetic rats. In normal rats, the water extract of SP decreased significantly the plasma glucose levels 4 h after single oral administration (P0.01), and one week after repeated oral administration (P0.05). A significant decrease of plasma glucose levels was observed 6 h after a single oral administration of the water extract of S. purpurea in severe hyperglycaemic rats (n=6) from 22.78+/-0.60 to 11.21+/-0.49 mmol/l (P0.001). On other hand, water extract of S. purpurea normalised plasma glucose levels aft…

Blood GlucoseMalemedicine.medical_specialtyBlood sugarPharmacognosyDiabetes Mellitus Experimentallaw.inventionLethal Dose 50MicelawOral administrationInternal medicineDiabetes mellitusDrug DiscoverymedicineAnimalsHypoglycemic AgentsInsulinRats WistarPharmacologyPlants MedicinalBehavior AnimalPlant Extractsbusiness.industryBody Weightmedicine.diseaseStreptozotocinRatsMoroccoEndocrinologyPhytochemicalToxicityPhytotherapybusinessmedicine.drugJournal of Ethnopharmacology
researchProduct